Large-scale testing (Phase 3)UnknownNCT00003679What this trial is testingCombination Chemotherapy in Treating Women With Breast CancerWho this might be right forBreast Cancer Scottish Cancer Therapy Network 350
Testing effectiveness (Phase 2)WithdrawnNCT01814865What this trial is testingAnti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast CancerWho this might be right forPost-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer British Columbia Cancer Agency
Testing effectiveness (Phase 2)Study completedNCT03395899What this trial is testingPre-operative Immunotherapy Combination Strategies in Breast CancerWho this might be right forBreast CancerEstrogen Receptor-positive Breast Cancer Queen Mary University of London 71
Testing effectiveness (Phase 2)Study completedNCT00422903What this trial is testingLetrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast CancerWho this might be right forNeoplasms, Breast GlaxoSmithKline 92
Testing effectiveness (Phase 2)Study completedNCT02760030What this trial is testingEndocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by SurgeryWho this might be right forEstrogen Receptor and/or Progesterone Receptor PositiveHER2/Neu NegativeStage IA Breast Cancer+6 more Ohio State University Comprehensive Cancer Center 14
Not applicableUnknownNCT00502684What this trial is testingPerioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer SurgeryWho this might be right forPrimary Operable Breast Cancer Kaplan Medical Center 32
Large-scale testing (Phase 3)Study completedNCT01314833What this trial is testingMinus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer TherapyWho this might be right forPrimary Breast Cancer Fudan University 1,570
Large-scale testing (Phase 3)Study completedNCT01966471What this trial is testingTrastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 1,846
Large-scale testing (Phase 3)Study completedNCT00123669What this trial is testingPrimary Progesterone Therapy for Operable Breast CancerWho this might be right forBreast Neoplasms Tata Memorial Hospital 1,000
Large-scale testing (Phase 3)Study completedNCT01358877What this trial is testingPertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 4,804
Testing effectiveness (Phase 2)Study completedNCT00559754What this trial is testingAvastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.Who this might be right forBreast Cancer Hoffmann-La Roche 72
Testing effectiveness (Phase 2)Ended earlyNCT00148720What this trial is testingCapecitabine in Women With Operable Breast CancerWho this might be right forInvasive Breast CarcinomaPrimary Invasive Breast CancerStage I Breast Cancer+2 more Dana-Farber Cancer Institute 80
Testing effectiveness (Phase 2)Study completedNCT00301548What this trial is testingPerioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast CancerWho this might be right forBreast NeoplasmsCarcinoma European Institute of Oncology 172
Not applicableLooking for participantsNCT06830590What this trial is testingStudy of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani PopulationWho this might be right forBreast CancerMolecular Pathway DeregulationTreatment Liaquat University of Medical & Health Sciences 300
Testing effectiveness (Phase 2)Study completedNCT00532857What this trial is testingPhase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and TrastuzumabWho this might be right forBreast Cancer Jungsil Ro 53
Testing effectiveness (Phase 2)Study completedNCT00203502What this trial is testingPrimary Systemic Therapy in Operable/Locally Advanced Breast CancerWho this might be right forBreast Cancer University of Arkansas 40
Testing effectiveness (Phase 2)WithdrawnNCT00434031What this trial is testingCETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast CancerWho this might be right forBreast Cancer National Cancer Institute, Naples
Early research (Phase 1)Study completedNCT00008034What this trial is testingCombination Chemotherapy Before Surgery in Treating Women With Breast CancerWho this might be right forBreast Cancer European Organisation for Research and Treatment of Cancer - EORTC 15
Testing effectiveness (Phase 2)Ended earlyNCT01985841What this trial is testingBevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast CancerWho this might be right forBreast Cancer Hellenic Oncology Research Group 34
Large-scale testing (Phase 3)UnknownNCT01019616What this trial is testingAlternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary ChemotherapyWho this might be right forPrimary Breast Cancer Tao OUYANG 400